This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Tenacia Biotechnology (Hong Kong) Co., Limited. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Mohsen Arghavani: Innovator in Diabetic Neuropathy Treatment
Introduction
Mohsen Arghavani is an accomplished inventor based in Lake In the Hills, IL (US). He has made significant contributions to the field of medicine, particularly in the treatment of painful diabetic peripheral neuropathy (DPN). His innovative approaches aim to improve the quality of life for patients suffering from this debilitating condition.
Latest Patents
Arghavani holds a patent for "Methods of treating painful diabetic peripheral neuropathy." This patent outlines methods for treating advanced painful DPN by administering an effective amount of NYX-2925 or a pharmaceutically acceptable salt thereof. Additionally, the patent includes crystalline forms of 3-hydroxy-2-(5-isobutyryl-1-oxo-2,5-diazaspiro[3,4]octan-2-yl)butanamide. This work represents a significant advancement in the management of diabetic neuropathy.
Career Highlights
Throughout his career, Mohsen Arghavani has worked with notable companies, including Tenacia Biotechnology Co., Limited and Naurex, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.
Collaborations
Arghavani has collaborated with esteemed colleagues, including M Amin Khan and Phil Bauer. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medical research.
Conclusion
Mohsen Arghavani's contributions to the treatment of painful diabetic peripheral neuropathy highlight his dedication to improving patient outcomes through innovative solutions. His work continues to inspire advancements in the medical field.